For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, such therapies often remain ineffective. Now Japanese scientists are providing a possible way out: a combination of two bacteria that control each other and attack cancer even without the help of the immune system.
The new therapy could help above all those people whose immune system is exhausted after cancer therapy – and for whom there are hardly any treatment options so far.
Two microbes, one task
A research team led by Eijiro Miyako from the Japan Advanced Institute of Science and Technology has combined two natural bacterial species: Proteus mirabilis and Rhodopseudomonas palustris. In a ratio of three to 97 percent, they form a consortium that the researchers call "AUN" – after a Japanese term for harmony.
These two microbes behave like partners: Proteus mirabilis penetrates deep into tumor tissue and changes its shape there to attack cancer cells. Rhodopseudomonas palustris regulates the process and prevents the bacteria from getting out of control or triggering inflammation. This creates a finely balanced balance that destroys tumors from the inside out, but spares healthy tissue.
"After 150 years, a new chapter in bacteria-based cancer therapy is finally beginning," says study leader Miyako. He is alluding to the fact that scientists first researched bacterial cancer treatment 150 years ago.
"Suffocating" the tumor
In the study published in the journal Nature Biomedical Engineering, the scientists investigated what happens in the body when AUN enters the bloodstream. The bacteria find their way to the tumour and begin to change its blood supply. Small clots form in the fine vessels, which only occur in the tumour tissue. As a result, the cancer is cut off from oxygen – it "suffocates" from the inside.
At the same time, the bacteria form fibre-like structures with which they directly attack cancer cells. This combined effect leads to a massive necrosis, i.e. to the death of the tumour tissue.
Teamwork significantly increases the impact
The team found that a two-stage treatment is particularly effective: first a small dose to accustom the immune system to the bacteria, followed by a higher dose. This procedure led to a complete decrease in tumours in all experiments – while at the same time being well tolerated.
Hope even for weak patients
Classic immunotherapies, such as so-called checkpoint inhibitors or CAR-T cell therapies, only work when the body's own defences are intact. In people who have already had several chemotherapy treatments, they usually remain unsuccessful. This is exactly where the new concept cats in: The bacteria attack tumours independently of Defence cells.
In the study, the researchers reported:
AUN completely eliminated tumours – even in animals whose immune system was barely active.
This opens up a completely new way of treatment for patients who have previously had no chance of immunotherapy.
No genetically modified microbes
Particularly remarkable: The researchers did not have to genetically modify the microbes. Both species exist in nature – Proteus mirabilis can also be found in small quantities in the human body, Rhodopseudomonas palustris in soils and waters.
They adapt in the tumour environment: one bacterium becomes more mobile and aggressive, the other ensures that the attack remains targeted. If unwanted reactions occur, the system can be stopped with common antibiotics. This could make the use for patients one day much safer than previous bacterial therapies.
Clinical study planned
The method is not yet approved for clinical practice. The team around Miyako is currently preparing the first studies with humans. In the coming years, safety, dosage and efficacy are to be tested.
The goal is to develop a therapy that fights tumours regardless of the state of the immune system. If this succeeds, AUN therapy could create a new treatment option – for those patients who previously had no hope of recovery.
Summary:
- A Japanese study shows that two naturally occurring bacteria can destroy cancer without needing the immune system.
- The bacteria specifically block the blood supply to cancer cells and trigger their death, while healthy cells are spared.
- The method is considered a hope for patients whose immune system is severely weakened after chemotherapy or radiation therapy.
Von Anne Bajrica
The original of this article "New bacterial therapy destroys cancer even with a weakened immune system" comes from Smart Up News.
News
Why music from your youth still has such an intense effect years later: A psychological perspective
You're driving, and suddenly a familiar song fills the air. Before you even know it, a wave of emotions comes over you – not just memories, but a deep, almost physical feeling. This powerful [...]
AI to antibody in days: breaking the wet lab bottleneck via high-throughput integration
The role of artificial intelligence (AI) in drug design has fundamentally shifted from a speculative tool to a central pillar of pharmaceutical research and development (R&D). Sino Biological plays a critical role in this [...]
Regenerative Healthcare by Design: Engineering Health-Centric Buildings and Urban Ecosystems
Introduction The next evolution of healthcare will not be confined to hospitals, clinics, or episodic interventions—it will be embedded into the infrastructure of everyday life. Regenerative health ecosystems require a systemic re-architecture of how [...]
Scientists Warn: Humanity Has Pushed the Planet Past Its Limits
Human population and consumption have surpassed Earth’s limits, increasing risks to climate and global stability. The Earth is already operating beyond its capacity to sustainably support the global population, according to new research highlighting [...]
Breakthrough Study Reveals Why Damaged Nerves Struggle To Heal
A newly identified molecular mechanism reveals how neurons weigh survival against repair after injury. Scientists at the Icahn School of Medicine at Mount Sinai have identified a molecular switch in neurons that limits the regrowth of [...]
Popular Vitamin B3 Supplements May Help Cancer Cells Survive, Scientists Warn
A new study raises important questions about widely used NAD+ supplements, suggesting that compounds often taken to boost energy and support healthy aging may have unintended consequences in cancer treatment. Millions of Americans take [...]
Scientists Discover Cancer Tumors Are “Addicted” to This Common Antioxidant
Cancer cells may be exploiting a common antioxidant as fuel, revealing a potential weakness that future therapies could target. Cancer cells may be tapping into an unexpected energy source: an antioxidant long associated with [...]
Nanotube injector transfers cytoplasmic contents and organelles between living cells safely
Cells are not isolated units; they continuously exchange proteins, genetic material, and even entire organelles with their neighbors. Intercellular transfer influences how tissues develop, respond to stress, and repair damage. In certain cancers, for [...]
CEO of America’s largest public hospital system is ready to replace radiologists with AI
The chief executive of America’s largest public hospital system says he is prepared to start replacing radiologists with artificial intelligence in some circumstances, once the regulatory landscape catches up. Mitchell H. Katz, MD, president [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Study finds higher heart disease risk in long COVID patients
People with long COVID are at increased risk of developing cardiovascular disease, according to a new study from Karolinska Institutet published in eClinicalMedicine. The results show that the risk of conditions such as cardiac arrhythmias [...]
The Corona variant Cicada is here – we know that
Online and on social media, reports are piling up about a new Sars-Cov-2 variant that is currently on the rise: BA.3.2, also known as Cicada. That's what it's all about: The Omicron variant BA.3.2, [...]
A Simple Blood Test Could Predict Dementia Risk 25 Years Early
A single blood marker may quietly signal dementia risk decades in advance. Scientists at the University of California, San Diego, have identified a blood signal that could forecast dementia risk decades before symptoms begin. Their [...]
Sperm Get Lost in Space and Scientists Finally Know Why
Having a baby in space may be far more complicated than expected, as new research shows sperm struggle to find their way in microgravity. Starting a family beyond Earth could be more complicated than [...]
Digital Dementia – Brain fog and disassociation from being chronically online
New medical evidence, featured on 60 Minutes Australia, indicates excessive screen time is causing "digital dementia" in young Australians, with brain scans showing physical shrinkage and damage. Experts warn that high device usage (6-8 hours [...]
A new, highly mutated COVID variant called ‘Cicada’ is spreading in the US.
BA.3.2, a heavily mutated new COVID-19 variant which may be better able to escape immunity from vaccines or prior infection, is now spreading in the United States. Although COVID cases are currently low nationally, [...]















